News
Taking into account the ongoing post pandemic recovery, growth in the Safety-Engineered Insulin Pen Needles segment is readjusted to a revised 7.5% CAGR for the next 8-year period.
“The safety notice issued by the FDA on November 30, 2023, only applies to plastic syringes made in China, and therefore has no impact on the ongoing production or sale of any embecta syringe ...
For decades, needle-based injections have been the main method for delivering large biological molecules such as insulin and vaccine components, but an aversion to needles is a significant reason ...
Retractable Needle Safety Syringes Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Com ...
Insulin syringes and vials are usually the least expensive options. Pens and pumps may be more convenient than syringes and vials, but they can be unaffordable even with insurance.
The original introduction of a variety of insulin concentrations necessitated the construction of hypodermic syringes with different calibrations corresponding to these various concentrations.
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the ...
FMI’s data reveals a market stretched across two extremes. On one hand, North America accounts for 42.5% of global syringe ...
After the FDA announced an investigation into China-made plastic syringes, NJ-based companies are assuring the public their devices are safe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results